OTC Healthcare in Uzbekistan
Euromonitor International's OTC Healthcare in Uzbekistan market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 10 | Publication date: Jan 2007
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; Vitamins and dietary supplements; Wound treatments
Executive summary
Difficult environment for growth
A number of factors continue to constrain growth in OTC healthcare, including state bureaucracy, currency controls and a thriving black market. Low consumer incomes, poor distribution and government cutbacks also hit sales hard during the review period. As a result, there was little investment in new product development and marketing, with current value sales declining in 2005 over the previous year.
Digestive remedies popular due to cuisine
Digestive remedies achieved the best performance in 2005, whilst still experiencing current value decline over the previous year. These were supported by two factors, the rich and fatty diet in Uzbekistan and the high incidence of infant diarrhoea. Sales are also supported by lengthy fasting periods in this Islamic country, with many breaking their fast with rich meals and suffering as a result.
Multinationals dominate but domestic players on the up
Domestic OTC healthcare production still has considerable room for development and is unable to satisfy consumer requirements in Uzbekistan. Consequently, multinationals dominate value sales, with the leading company being Berlin-Chemie AG in 2005.
However, the government is keen to encourage growth in domestic players, in order to reduce dependence on expensive imports and to fill gaps in demand. Consequently, the government introduced tax benefits for domestic medicine producers at the start of 2006, which is expected to result in good growth for domestic players during the forecast period.
Distribution limited to chemists/pharmacies
The distribution of OTC healthcare continues to be limited to chemists/pharmacies, constraining growth in sales. Sales benefited from a good expansion in the number of chemists/pharmacies present in Uzbekistan during the review period and by the growing presence of chained players. However, distribution continues to be skewed to the eastern region of the country and Tashkent, the capital.
Good growth for forecast period driven by growing strength of domestic players
Sales are expected to see strong growth during the forecast period, despite the continuing presence of many negative factors. Currency controls, distribution restrictions and low disposable incomes are all expected to continue into the forecast period. However, the growing strength of domestic players, aided by the introduction of tax benefits, is expected to underpin prospective growth. In addition, chained chemists/pharmacies are expected to expand further across Uzbekistan, resulting in more even distribution across the country.
Eye care is expected to see the most dynamic growth in constant value terms during the forecast period. This will be chiefly due to leading player Nizhpharm. Nizhpharm opened representative offices in Uzbekistan in 2006 and is expected to focus on building its sales in the country during the forecast period.
Table of contents
OTC HEALTHCARE IN UZBEKISTAN : MARKET INSIGHT
1. EXECUTIVE SUMMARY
2. OPERATING ENVIRONMENT
2.1 OTC Registration and Classification
2.2 Vitamins & Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homeopathy
2.9 Generics
2.10 Life Expectancy
Table 1 Life Expectancy at Birth 1998-2003
3. OTC HEALTHCARE SALES
3.1 Market Performance
Table 2 Retail Sales of OTC Healthcare by Sector: Value 2000-2005
Table 3 Retail Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
3.2 Switches
3.3 Competitive Environment
Table 4 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 5 OTC Healthcare Brand Shares by Retail Value 2002-2005
3.4 Leading Company Profile: Nizhpharm OAO
Summary 1 Nizhpharm OAO: Operational Indicators 2005
3.5 Leading Company Profile: Uzkhimpharm OAO
3.6 New Product Developments
3.7 Retail Distribution
Table 6 Retail Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 7 Retail Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
3.8 Retailer Activity and Private Label Trends
3.9 Forecast Market Performance
Table 8 Forecast Retail Sales of OTC Healthcare by Sector: Value 2005-2010
Table 9 Forecast Retail Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
4. DEFINITIONS